AstraZeneca: Merseyside
Commons · Question 32491 · Tabled 21 Feb 2025 · Department for Science, Innovation and Technology · Official record
Answered 3 Mar 2025
Question
Asked by Clive Jones
To ask the Secretary of State for Science, Innovation and Technology, if he will make it his policy to conduct a lessons learned review following the negotiations with AstraZeneca for investment in Speke.
Answer
Answered by Feryal Clark, 3 Mar 2025
AstraZeneca’s decision not to invest in Speke is deeply disappointing. The Government regularly reviews it’s grant process and routinely seeks applicant feedback. The Government also continues to engage positively with AstraZeneca, including on the new In...